ZYC-300

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameZYC-300
Drug Alias NameE-7300ZYC-300
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsKidney NeoplasmsProstatic NeoplasmsOvarian Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEisai Inc
Active IndicationsN/A
Inactive IndicationsKidney NeoplasmsProstatic NeoplasmsOvarian Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A